FRINK Linked Data Fragments server

Matches in SemOpenAlex for { <https://semopenalex.org/work/W2328200986> ?p ?o ?g. }

• W2328200986 endingPage "883" @default.
• W2328200986 startingPage "883.2" @default.
• W2328200986 abstract "<h3>Background</h3> Rheumatoid arthritis (RA) treatment in Australia has undergone significant change in the last decade. New treatment paradigms of treat to target, with remission being the goal, supplemented by maintenance of tight control have become standard of care. We have established a network database, named OPAL-QUMI (Optimising Patient outcome in Australian RheumatoLogy – Quality Use of Medicines) whereby patient-specific details are captured on purpose-written software at the time of consultation. This information represents real-life data reflecting everyday care of the patient. We used this database to assess surrogates of disease activity over the 5-year period that our consortium has been in place (2009-2013). <h3>Objectives</h3> To evaluate the disease activity trends in rheumatoid arthritis (RA) patients in Australia over 5 years. <h3>Methods</h3> RA patients treated in participating Australian clinics were included in the study. Patient demographics, disease onset, medications and disease measures were analysed. Data, de-identified to the patient, clinic and clinician was captured using an electronic clinical management programme. The disease activity score (DAS28) was used to classify patients into the disease activity states of remission, low disease activity (LDA), moderate disease activity (MDA) and high disease activity (HDA). Choice of therapy was at the discretion of the treating clinician. <h3>Results</h3> A total of 8,458 patients, 72.3% female, 27.3% male with mean age 62.1 (SD 13.9) years and mean disease duration of 13.0 (SD 10.9) years were analysed. There were 31,023 individual DAS28 ESR values recorded in the patient group. Of these patients 45.6% were in remission, 17.1% in LDA, 28.1% in MDA and 9.2% in HDA. The percentage of patients in remission increased from 37.4% (2009) to 52.5% (2013) over the 5-year analysis period, with those in MDA falling from 32.7% to 23.5%, with reduction also in LDA from 19.1% to 16.15% and HDA from 10.8% to 7.9%. The use of biologic disease modifying antirheumatic drugs increased from 22.8% to 37.9% over the same time period. <h3>Conclusions</h3> Serial cross-sectional assessment of this large cohort of Australian RA patients showed significant increases in lower disease activity scores, with more patients in the remission and less in moderate disease activity groups over 5 years. Contemporary management of RA in Australia shows improvement in disease activity targets. <h3>Disclosure of Interest</h3> G. Littlejohn: None declared, L. Roberts: None declared, P. Bird: None declared, J. de Jager: None declared, H. Griffiths: None declared, D. Nicholls: None declared, J. Young Employee of: Roche Products, Pty. Limited, J. Zochling: None declared, K. Tymms: None declared <h3>DOI</h3> 10.1136/annrheumdis-2014-eular.4834" @default.
• W2328200986 created "2016-06-24" @default.
• W2328200986 creator A5004544171 @default.
• W2328200986 creator A5026348857 @default.
• W2328200986 creator A5033638242 @default.
• W2328200986 creator A5040650255 @default.
• W2328200986 creator A5049894404 @default.
• W2328200986 creator A5053200902 @default.
• W2328200986 creator A5063546370 @default.
• W2328200986 creator A5083929997 @default.
• W2328200986 creator A5086576051 @default.
• W2328200986 date "2014-06-01" @default.
• W2328200986 modified "2023-10-16" @default.
• W2328200986 title "AB0241 Rheumatoid Arthritis Patients in Australian Database Show Significant Improvement in Disease Activity over 5 Years" @default.
• W2328200986 doi "https://doi.org/10.1136/annrheumdis-2014-eular.4834" @default.
• W2328200986 hasPublicationYear "2014" @default.
• W2328200986 type Work @default.
• W2328200986 sameAs 2328200986 @default.
• W2328200986 citedByCount "0" @default.
• W2328200986 crossrefType "journal-article" @default.
• W2328200986 hasAuthorship W2328200986A5004544171 @default.
• W2328200986 hasAuthorship W2328200986A5026348857 @default.
• W2328200986 hasAuthorship W2328200986A5033638242 @default.
• W2328200986 hasAuthorship W2328200986A5040650255 @default.
• W2328200986 hasAuthorship W2328200986A5049894404 @default.
• W2328200986 hasAuthorship W2328200986A5053200902 @default.
• W2328200986 hasAuthorship W2328200986A5063546370 @default.
• W2328200986 hasAuthorship W2328200986A5083929997 @default.
• W2328200986 hasAuthorship W2328200986A5086576051 @default.
• W2328200986 hasConcept C126322002 @default.
• W2328200986 hasConcept C144024400 @default.
• W2328200986 hasConcept C149923435 @default.
• W2328200986 hasConcept C159110408 @default.
• W2328200986 hasConcept C1862650 @default.
• W2328200986 hasConcept C198451711 @default.
• W2328200986 hasConcept C2777077863 @default.
• W2328200986 hasConcept C2777575956 @default.
• W2328200986 hasConcept C2779134260 @default.
• W2328200986 hasConcept C2779951463 @default.
• W2328200986 hasConcept C2780084366 @default.
• W2328200986 hasConcept C41008148 @default.
• W2328200986 hasConcept C71924100 @default.
• W2328200986 hasConcept C77088390 @default.
• W2328200986 hasConceptScore W2328200986C126322002 @default.
• W2328200986 hasConceptScore W2328200986C144024400 @default.
• W2328200986 hasConceptScore W2328200986C149923435 @default.
• W2328200986 hasConceptScore W2328200986C159110408 @default.
• W2328200986 hasConceptScore W2328200986C1862650 @default.
• W2328200986 hasConceptScore W2328200986C198451711 @default.
• W2328200986 hasConceptScore W2328200986C2777077863 @default.
• W2328200986 hasConceptScore W2328200986C2777575956 @default.
• W2328200986 hasConceptScore W2328200986C2779134260 @default.
• W2328200986 hasConceptScore W2328200986C2779951463 @default.
• W2328200986 hasConceptScore W2328200986C2780084366 @default.
• W2328200986 hasConceptScore W2328200986C41008148 @default.
• W2328200986 hasConceptScore W2328200986C71924100 @default.
• W2328200986 hasConceptScore W2328200986C77088390 @default.
• W2328200986 hasIssue "Suppl 2" @default.
• W2328200986 hasLocation W23282009861 @default.
• W2328200986 hasOpenAccess W2328200986 @default.
• W2328200986 hasPrimaryLocation W23282009861 @default.
• W2328200986 hasRelatedWork W1834687338 @default.
• W2328200986 hasRelatedWork W1836540390 @default.
• W2328200986 hasRelatedWork W1998237860 @default.
• W2328200986 hasRelatedWork W2007849701 @default.
• W2328200986 hasRelatedWork W2092868594 @default.
• W2328200986 hasRelatedWork W2125233586 @default.
• W2328200986 hasRelatedWork W2319341778 @default.
• W2328200986 hasRelatedWork W2399595352 @default.
• W2328200986 hasRelatedWork W2410978906 @default.
• W2328200986 hasRelatedWork W18291341 @default.
• W2328200986 hasVolume "73" @default.
• W2328200986 isParatext "false" @default.
• W2328200986 isRetracted "false" @default.
• W2328200986 magId "2328200986" @default.
• W2328200986 workType "article" @default.